Consolidated Statement Of Cash Flows

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7328356

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
9,862,000,000 JPY
2,467,000,000 JPY
603,000,000 JPY
5,357,000,000 JPY
Depreciation
2,662,000,000 JPY
3,127,000,000 JPY
Interest and dividend income
-335,000,000 JPY
-338,000,000 JPY
Interest expenses
40,000,000 JPY
50,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
41,000,000 JPY
19,000,000 JPY
Decrease (increase) in trade receivables
-370,000,000 JPY
-742,000,000 JPY
Subtotal
2,724,000,000 JPY
3,916,000,000 JPY
Decrease (increase) in inventories
-2,713,000,000 JPY
-2,627,000,000 JPY
Income taxes paid
-1,611,000,000 JPY
-850,000,000 JPY
Net cash provided by (used in) operating activities
1,486,000,000 JPY
3,351,000,000 JPY
Increase (decrease) in trade payables
1,494,000,000 JPY
-980,000,000 JPY
Other, net
642,000,000 JPY
322,000,000 JPY
Interest and dividends received
414,000,000 JPY
337,000,000 JPY
Interest paid
-41,000,000 JPY
-51,000,000 JPY
Cash flows from investing activities
Purchase of securities
-500,000,000 JPY
-400,000,000 JPY
Purchase of property, plant and equipment
-1,320,000,000 JPY
-461,000,000 JPY
Proceeds from sale of property, plant and equipment
1,000,000 JPY
0 JPY
Net cash provided by (used in) investing activities
1,706,000,000 JPY
-1,126,000,000 JPY
Purchase of investment securities
-352,000,000 JPY
JPY
Proceeds from sale of investment securities
4,230,000,000 JPY
190,000,000 JPY
Other, net
845,000,000 JPY
-170,000,000 JPY
Cash flows from financing activities
Dividends paid
-792,000,000 JPY
-452,000,000 JPY
Repayments of long-term borrowings
-3,138,000,000 JPY
-1,423,000,000 JPY
Net cash provided by (used in) financing activities
-3,943,000,000 JPY
-1,820,000,000 JPY
Other, net
-22,000,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-15,000,000 JPY
-2,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-766,000,000 JPY
402,000,000 JPY
Cash and cash equivalents
16,738,000,000 JPY
17,505,000,000 JPY
17,103,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.